302 related articles for article (PubMed ID: 34610875)
1. Misconceptions and Facts About Cardiac Amyloidosis.
Nguyen FD; Rodriguez M; Krittanawong C; Witteles R; Lenihan DJ
Am J Cardiol; 2021 Dec; 160():99-105. PubMed ID: 34610875
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
3. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
4. A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy.
Zhang KW; Zhang R; Deych E; Stockerl-Goldstein KE; Gorcsan J; Lenihan DJ
Am Heart J; 2021 Feb; 232():137-145. PubMed ID: 33212046
[TBL] [Abstract][Full Text] [Related]
5. Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis.
Sperry BW; Vranian MN; Hachamovitch R; Joshi H; Ikram A; Phelan D; Hanna M
J Am Heart Assoc; 2016 Mar; 5(3):e002877. PubMed ID: 27013539
[TBL] [Abstract][Full Text] [Related]
6. Baseline ECG Features and Arrhythmic Profile in Transthyretin Versus Light Chain Cardiac Amyloidosis.
Cappelli F; Vignini E; Martone R; Perlini S; Mussinelli R; Sabena A; Morini S; Gabriele M; Taborchi G; Bartolini S; Lossi A; Nardi G; Marchionni N; Di Mario C; Olivotto I; Perfetto F
Circ Heart Fail; 2020 Mar; 13(3):e006619. PubMed ID: 32164434
[No Abstract] [Full Text] [Related]
7. Epidemiology and clinical manifestations of cardiac amyloidosis.
Bajwa F; O'Connor R; Ananthasubramaniam K
Heart Fail Rev; 2022 Sep; 27(5):1471-1484. PubMed ID: 34694575
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Amyloidosis: Mimics, Multimodality Imaging Diagnosis, and Treatment.
Fazlinezhad A; Naqvi TZ
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1384-1391. PubMed ID: 32061555
[No Abstract] [Full Text] [Related]
9. [What should we know about cardiac amyloidosis? From clinical signs to treatment].
Földeák D; Nemes A; Kalapos A; Domsik P; Kormányos Á; Krenács L; Bagdi E; Borbényi Z
Orv Hetil; 2017 Nov; 158(46):1811-1818. PubMed ID: 29135289
[TBL] [Abstract][Full Text] [Related]
10. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
Fontana M; Ćorović A; Scully P; Moon JC
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
[TBL] [Abstract][Full Text] [Related]
11. Understanding and recognizing cardiac amyloidosis.
McVeigh T; Tennyson C
JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
[TBL] [Abstract][Full Text] [Related]
12. Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options.
Alkhawam H; Patel D; Nguyen J; Easaw SM; Al-Sadawi M; Syed U; Zaiem F; Homsi M; Vittorio TJ
Acta Cardiol; 2017 Aug; 72(4):380-389. PubMed ID: 28705053
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Amyloidosis: Diagnosis and Treatment Strategies.
Tuzovic M; Yang EH; Baas AS; Depasquale EC; Deng MC; Cruz D; Vorobiof G
Curr Oncol Rep; 2017 Jul; 19(7):46. PubMed ID: 28528458
[TBL] [Abstract][Full Text] [Related]
14. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
Cuddy SAM; Bravo PE; Falk RH; El-Sady S; Kijewski MF; Park MA; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Cheng SC; Jerosch-Herold M; Kwong RY; Liao R; Dorbala S
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1325-1336. PubMed ID: 32417333
[TBL] [Abstract][Full Text] [Related]
15. Amyloid cardiomyopathy.
Kristen AV
Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
[TBL] [Abstract][Full Text] [Related]
16. Emerging therapy in light-chain and acquired transthyretin-related amyloidosis: an Italian single-centre experience in heart transplantation.
Di Nora C; Sponga S; Ferrara V; Patriarca F; Fanin R; Nalli C; Lechiancole A; Vendramin I; Livi U
J Cardiovasc Med (Hagerstown); 2021 Apr; 22(4):261-267. PubMed ID: 33633041
[TBL] [Abstract][Full Text] [Related]
17. The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosis.
Kwok CS; Moody WE
Ther Adv Cardiovasc Dis; 2023; 17():17539447231216318. PubMed ID: 38099406
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive detection and differentiation of cardiac amyloidosis using
Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive Mapping of the Electrophysiological Substrate in Cardiac Amyloidosis and Its Relationship to Structural Abnormalities.
Orini M; Graham AJ; Martinez-Naharro A; Andrews CM; de Marvao A; Statton B; Cook SA; O'Regan DP; Hawkins PN; Rudy Y; Fontana M; Lambiase PD
J Am Heart Assoc; 2019 Sep; 8(18):e012097. PubMed ID: 31496332
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.
González-López E; López-Sainz Á; Garcia-Pavia P
Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):991-1004. PubMed ID: 28870641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
